Table 3.

Banff histopathological features at diagnosis of cABMR

	Treatment (N=23)	Control (N=39)	P value
MVI (g+tc)	2.78 ± 1.35	2.87 ± 1.36	0.67
i	0.6 ± 0.78	0.56 ± 0.65	0.95
t	0.17 ± 0.49	0.25 ± 0.69	0.97
g	1.52 ± 0.94	1.4± 0.94	0.63
ptc	1.26 ± 0.86	1.4 ± 0.79	0.4
ah	1.43 ± 1.04	1.38 ± 1.1	0.91
cg	1.74 ± 0.83	1.83 ± 0.77	0.54
ci	1.52 ± 0.79	1.83 ± 0.88	0.17
ct	1.56 ± 0.73	1.67 ± 0.89	0.62
IFTA	1.61 ± 0.78	1.83 ± 0.84	0.27
cv	1.17 ± 0.83	1.39 ± 0.87	0.46
C4d deposition	19 (82.6%)	17 (43.6%)	0.01
acute cellular rejection	0	6	0.05

Results are shown as mean ± SD or absolute frequencies (%) for quantitative and qualitative variables respectively. i interstitial inflammation, t tubulitis, g glomerulitis, ptc peritubular capillaritis, ah arterial hyalinosis, cg transplant glomerulopathy, ci interstitial fibrosis, ct tubular atrophy, IFTA interstitial fibrosis + tubular atrophy, cv vascular fibrous intimal thickening